Ajanta Pharma Limited — Febuxostat Exporter Profile
Indian Pharmaceutical Exporter · #1 for Febuxostat · $4.5M export value · DGFT Verified
Ajanta Pharma Limited is the #1 Indian exporter of Febuxostat with $4.5M in export value and 89 verified shipments. Ajanta Pharma Limited holds a 9.1% market share in Febuxostat exports across 6 countries. The company exports 37 pharmaceutical products worth $116.1M across 17 therapeutic categories.
Ajanta Pharma Limited — Febuxostat Export Profile: Buyers & Destinations
Where Does Ajanta Pharma Limited Export Febuxostat?
| Country | Value | Shipments | Share |
|---|---|---|---|
| PHILIPPINES | $3.1M | 67 | 95.9% |
| VIETNAM, DEMOCRATIC REP. OF | $73.9K | 3 | 2.3% |
| BOLIVIA | $18.7K | 2 | 0.6% |
| TANZANIA | $18.2K | 6 | 0.6% |
| KENYA | $10.8K | 3 | 0.3% |
| KYRGHYSTAN | $10.6K | 8 | 0.3% |
Ajanta Pharma Limited exports Febuxostat to 6 countries. The largest destination is PHILIPPINES accounting for 95.9% of Ajanta Pharma Limited's Febuxostat shipments, followed by VIETNAM, DEMOCRATIC REP. OF (2.3%) and BOLIVIA (0.6%). These destinations reflect Ajanta Pharma Limited's established distribution network and regulatory approvals in key markets.
Who Are the Top Buyers of Febuxostat from Ajanta Pharma Limited?
| Buyer | Country | Value | Orders |
|---|---|---|---|
| UNILAB INC | PHILIPPINES | $1.8M | 39 |
| AJANTA PHARMA PHILIPPINES INC | PHILIPPINES | $1.2M | 25 |
| RITEMED PHILS. INC. | PHILIPPINES | $88.9K | 2 |
| DELTA IMPORT - EXPORT MEDICAL CO.LT | VIETNAM, DEMOCRATIC REP. OF | $62.8K | 2 |
| RITEMED PHILS INC | PHILIPPINES | $18.8K | 1 |
| SOUTH AMERICAN EXPRESS S.A., | BOLIVIA | $18.7K | 2 |
| ASTRA PHARMA (T) LTD | TANZANIA | $18.2K | 6 |
| DELTA IMPORT - EXPORT MEDICAL | VIETNAM, DEMOCRATIC REP. OF | $11.1K | 1 |
| HARLEY S LIMITED | KENYA | $7.7K | 1 |
| NEMAN # PHARM LLC | KYRGHYSTAN | $6.7K | 4 |
Ajanta Pharma Limited supplies Febuxostat to 13 buyers globally. The largest buyer is UNILAB INC (PHILIPPINES), followed by AJANTA PHARMA PHILIPPINES INC (PHILIPPINES) and RITEMED PHILS. INC. (PHILIPPINES). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.
What Is India's Total Febuxostat Export Value and How Much Does Ajanta Pharma Limited Contribute?
India exported $24.2M worth of Febuxostat through 3,494 shipments from 182 suppliers to 91 countries, serving 421 buyers globally. Ajanta Pharma Limited contributes $4.5M to this total, accounting for 9.1% of India's Febuxostat exports. Ajanta Pharma Limited ships Febuxostat to 6 countries through 13 buyers.
What Is the Average Shipment Value for Ajanta Pharma Limited's Febuxostat Exports?
Ajanta Pharma Limited's average Febuxostat shipment value is $50.0K per consignment, based on 89 shipments totaling $4.5M. The largest destination is PHILIPPINES (95.9% of Ajanta Pharma Limited's Febuxostat exports).
How Does Ajanta Pharma Limited Compare to Other Indian Febuxostat Exporters?
Ajanta Pharma Limited ranks #1 among 182 Indian Febuxostat exporters with a 9.1% market share. The top 3 exporters are MSN LABORATORIES PRIVATE LIMITED ($6.0M), AJANTA PHARMA LIMITED ($4.5M), ALEMBIC PHARMACEUTICALS LIMITED ($2.8M). Ajanta Pharma Limited processed 89 shipments to 6 destination countries.
What Febuxostat Formulations Does Ajanta Pharma Limited Export?
| Product Description / Formulation | Value | Shipments |
|---|---|---|
| URINORM TAB 40MG FEBUXOSTAT TABLETS 40 M | $198.9K | 4 |
| URINORM TAB 40MG (FEBUXOSTAT TABLETS 40 | $150.0K | 3 |
| URINORM TAB 40MG FEBUXOSTAT TABLETS 40 | $150.0K | 3 |
| URINORM TAB 40MG (FEBUXOSTAT TABLETS 40MG)(114680 X 3 X 10 = 3440400 TABLETS)(EACH FILM COATED TABLET CONTAINS: FEBUXOSNOS | $150.0K | 3 |
| ATENURIX 40[105297PACKX3X10=3158910 TABS]EACH FILM COATED TAB CONT:FEBUXOSTAT 40MG] | $150.0K | 3 |
| ATENURIX TAB 20MG [52176 X 3 X 10 = 1565280 TABLETS] [EACH FILM COATED TABLET CONTAINS : FEBUXOSTAT 20 MGNOS | $148.4K | 3 |
| ATENURIX TAB 20MG[26112PACKx3x10=783360TABS]EACH FILM COATED TAB CONT:FEBUXOSTAT 20 MG | $100.0K | 2 |
| URINORM 80 18600 X 3 X 10 55800 TABLETS EACH FILM COATED TABLET CONTAINS FEBUXOSTAT 80 MG | $100.0K | 2 |
| ATENURIX 40 98770PACKx3x10 2963 100 TABS EACH FILM COATED TABLET CONTAINS FEBUXOSTAT 40MG | $50.0K | 1 |
| ATENURIX 40 110304PACKx3x10 3309120 TABS EACH FILM COATED TABS CONT FEBUXOSTAT40MG | $50.0K | 1 |
Ajanta Pharma Limited exports 73 distinct Febuxostat formulations including tablets, capsules, syrups, and combination drugs. The top formulation is URINORM TAB 40MG FEBUXOSTAT TABLETS 40 M with 4 shipments worth $198.9K.
How Does Ajanta Pharma Limited Compare to Nearest Febuxostat Exporters?
Exporters ranked immediately above and below #1 by export value
| # | Supplier | Export Value | Shipments | Countries | Avg/Shipment |
|---|---|---|---|---|---|
| 2 | MSN LABORATORIES PRIVATE LIMITED | $6.0M | 342 | 27 | $17.6K |
| 1 | AJANTA PHARMA LIMITED ★ | $4.5M | 89 | 6 | $50.0K |
| 3 | ALEMBIC PHARMACEUTICALS LIMITED | $2.8M | 56 | 1 | $50.0K |
| 5 | MACLEODS PHARMACEUTICALS LTD | $2.1M | 68 | 12 | $31.5K |
Ajanta Pharma Limited ranks #1 among 182 Indian Febuxostat exporters. Average shipment value of $50.0K compared to the market average of $132.8K. The closest competitors by value are MSN LABORATORIES PRIVATE LIMITED and ALEMBIC PHARMACEUTICALS LIMITED.
Which Indian Ports Ship Febuxostat Exports?
| Port | Shipments | % Share |
|---|---|---|
| DELHI AIR CARGO ACC (INDEL4) | 639 | 18.3% |
| SAHAR AIR | 615 | 17.6% |
| DELHI AIR | 387 | 11.1% |
| SAHAR AIR CARGO ACC (INBOM4) | 351 | 10.0% |
| NHAVA SHEVA SEA (INNSA1) | 145 | 4.1% |
| HYDERABAD ICD (INSNF6) | 98 | 2.8% |
| HYDERABAD AIR | 96 | 2.7% |
| Bombay Air | 84 | 2.4% |
What Other Lipid & Metabolism Products Does Ajanta Pharma Limited Export?
Ajanta Pharma Limited also exports these lipid & metabolism products. Each links to the detailed product page.
Geopolitical & Trade Policy Impact on Ajanta Pharma Limited's Febuxostat Exports
Ajanta Pharma's export operations are intricately linked to global trade routes, making them susceptible to geopolitical tensions. The ongoing Israel-Iran conflict has disrupted shipping lanes in the Red Sea, leading to increased freight costs and extended delivery timelines. Such disruptions pose challenges for Indian pharmaceutical exporters like Ajanta, necessitating adaptive logistics strategies to maintain supply chain integrity. (pharmaceuticalcommerce.com)
Conversely, the US-China trade tensions have opened avenues for Indian pharmaceutical companies to strengthen their foothold in the American market. India's pharmaceutical exports to the US surged by 74% in March 2025, indicating a shift in sourcing preferences. Ajanta Pharma can leverage this trend by emphasizing its compliance with stringent US regulatory standards and offering competitive pricing. (business-standard.com)
In the European Union, adherence to the Falsified Medicines Directive (FMD) is paramount. Indian exporters, including Ajanta, must ensure robust serialization and traceability measures to comply with these regulations. Non-compliance could result in restricted market access, underscoring the importance of investing in advanced tracking systems and quality assurance protocols.
Ajanta Pharma Limited — Regulatory Compliance & Quality Standards
The global pharmaceutical industry is witnessing heightened regulatory scrutiny, with agencies like the US FDA, WHO, and EU GMP setting stringent compliance benchmarks. India has made significant strides in this arena, surpassing the US in the number of FDA-registered generic manufacturing sites, boasting 752 FDA-approved facilities as of 2024. (business-standard.com) Ajanta Pharma's commitment to quality is evident in its adherence to these international standards, facilitating smoother market entry and bolstering its reputation among global stakeholders.
About Ajanta Pharma Limited
Ajanta Pharma Limited exports 37 products worth $116.1M. Beyond Febuxostat, top products include Artemether, Amlodipine, Clopidogrel, Rosuvastatin, Montelukast. View the complete Ajanta Pharma Limited profile for full portfolio analysis.
Market Intelligence
Latest developments and market context
Detailed market intelligence for Febuxostat — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Febuxostat shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
- 2.Supplier Identification: Ajanta Pharma Limited matched across shipments using name normalization, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
- 4.Verified Records: This page is backed by 89 individual customs records matching Ajanta Pharma Limited exporting Febuxostat, covering 73 formulations to 6 countries via 13 buyers.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 91+ countries, 421+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Febuxostat Export Data from Ajanta Pharma Limited
Access shipment-level details, pricing data, buyer connections, and competitive analysis for Ajanta Pharma Limited's Febuxostat exports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
Ajanta Pharma Limited
Full Company Profile →
37 products · $116.1M total trade · 17 categories
Febuxostat Stats
Company Overview
Top Products by Ajanta Pharma Limited
Related Analysis
Need Detailed Export Data?
Access shipment-level records, pricing trends, and buyer contacts for Ajanta Pharma Limited.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Febuxostat. For current shipment-level data, contact TransData Nexus.